DE

latest development

London (UK), Rehovot (Israel) July 26th, 2023
Vidac Pharma Holdings Plc. (SYM: T9G; ISIN: GB00BM9XQ619; WKN: A3DTUQ). www.vidacpharma.com
Vidac Pharma to hold Extraordinary Shareholder Meeting to prepare for potential investments.

Vidac Pharma Holding invited a Share Holders Meeting to be held in person and digitally on August 8, 2023 in order to create new Shares in preparation for potential off exchange investments. Details are published in the Company Site. Recent in-exchange investors who might not be in the Company list are invited to contact the Company with their details and number of shares. A link to the Meeting reserved only to Shareholders will be sent prior to the meeting.

Rehovot (Israel), London (UK)

About Vidac Pharma: Vidac Pharma Holdings Plc. London, is the holding company of Vidac Pharma Ltd. Rehovot. The Company is a clinical stage biopharmaceutical company dedicated to discovering and developing First-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases.

Disclaimer

The following information does not constitute a public offer to sell or a solicitation to submit an offer to buy or subscribe to shares of Vidac Pharma Holding PLC, but is for informational purposes only.

Vidac Pharma Holding PLC

Dr. Max Herzberg
20-22 Wenlock Road
London N1 7GU
United Kingdom

http://www.vidacpharma.com/
investors@vidacpharma.com

+972-54-4257381
+972 (0)779300647